Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gac, N. T. L.
Right arrow Articles by Boehmer, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gac, N. T. L.
Right arrow Articles by Boehmer, P. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 35, Issue of August 30, 1996 pp. 21645-21651
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

The UL8 Subunit of the Herpes Simplex Virus Type-1 DNA Helicase-Primase Optimizes Utilization of DNA Templates Covered by the Homologous Single-strand DNA-binding Protein ICP8*

(Received for publication, May 6, 1996, and in revised form, June 25, 1996)

Nicolas Tanguy Le Gac Dagger , Giuseppe Villani Dagger , Jean-Sébastien Hoffmann Dagger and Paul E. Boehmer §

From the § Department of Microbiology and Molecular Genetics, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey 07103 and the Dagger  Institut de Pharmacologie et de Biologie Structurale, CNRS, 205 Route de Narbonne, 31077 Toulouse Cédex, France

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgment
REFERENCES


ABSTRACT

The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes. The core enzyme, specified by the UL5 and UL52 genes, retains DNA helicase, DNA-dependent nucleoside triphosphatase, and primase activities. The UL8 subunit has previously been implicated in increasing primer stability and in stimulating primer synthesis by the core enzyme. To further characterize the function of the UL8 subunit, we have examined its effect on the activities of the UL5/52 core enzyme using DNA templates covered by the herpes simplex virus type-1 single-strand DNA-binding protein ICP8. We found that while ICP8 stimulated the DNA helicase activity of the UL5/52 proteins up to 3-fold, maximum stimulation by ICP8 required the presence of UL8 protein. Moreover, UL8 protein was required to reverse the inhibitory effect of ICP8 on the DNA-dependent ATPase and primase activities of the UL5/52 proteins. These observations were specific for ICP8 since the heterologous Escherichia coli single-strand DNA-binding protein could not substitute for ICP8. These data suggest that UL8 protein mediates an interaction between the UL5/52 core enzyme and ICP8 that optimizes the utilization of ICP8-covered DNA templates during DNA replication.


INTRODUCTION

Herpes simplex virus type-1 (HSV-1)1 is a double-strand DNA virus with a genome of ~152 kilobase pairs and three origins of DNA replication (Challberg, 1991). Replication of origin-containing plasmids requires the action of seven viral gene products (Stow, 1992; Wu et al., 1988). These seven gene products comprise a highly processive heterodimeric DNA polymerase (UL30/UL42 genes), a heterotrimeric DNA helicase-primase (UL5/UL8/UL52 genes), a single-strand DNA-binding protein (SSB) (UL29 gene), and an origin-binding protein (UL9 gene) (reviewed by Challberg (1991)).

HSV-1 SSB, henceforth referred to as ICP8 (<UNL>i</UNL>nfected <UNL>c</UNL>ell <OVL>p</OVL>olypeptide <UNL>8</UNL>), is a 128-kDa zinc metalloprotein (Gupte et al., 1991). It is a functional homologue of Escherichia coli SSB (E-SSB) (Lohman and Ferrari, 1994), capable of binding to single-strand DNA cooperatively and with high affinity (Lee and Knipe, 1985; Ruyechan, 1983). The DNA-binding site size for ICP8 is based on indirect measurements. Estimates based on the ratios of ICP8 required for stimulation of the HSV-1 DNA polymerase, strand displacement activity, and nuclease protection fall in the range of one ICP8 to 12-22 nucleotides (Boehmer and Lehman, 1993b; Hernandez and Lehman, 1990; O'Donnell et al., 1987). They are consistent with a site size of 15-18 nucleotides estimated by electron microscopy (Makhov et al., 1996). In addition to its role as an SSB, ICP8 participates in multiple protein-protein interactions that are probably significant during viral DNA replication (Boehmer and Lehman, 1993a; Boehmer et al., 1994; Chiou et al., 1985; Hernandez and Lehman, 1990; Liptak et al., 1996; Lukonis and Weller, 1996; Thomas et al., 1992; Vaughan et al., 1985).

The HSV-1 DNA helicase-primase is thought to be responsible for DNA unwinding and priming of Okazaki fragments at the DNA replication fork (Crute et al., 1989). The core enzyme consists of the 99-kDa UL5 and 114-kDa UL52 gene products and possesses 5' right-arrow 3' DNA helicase, DNA-dependent nucleoside triphosphatase, and primase activities (Calder and Stow, 1990; Dodson and Lehman, 1991). The primase activity exhibits sequence preference, with the predominant template site in phi X174 DNA being 3'-AG<UNL>C</UNL>CCTCCCA, with primer synthesis initiating at the underlined C residue (Tenney et al., 1995). The 80-kDa UL8 gene product lacks detectable enzymatic and DNA binding activities (Dodson and Lehman, 1991; Parry et al., 1993), but has been reported to stimulate primer synthesis by the UL5/52 core enzyme (Tenney et al., 1994). In addition, it has been proposed that UL8 protein increases utilization of primers synthesized by the UL5/52 proteins (Sherman et al., 1992).

This work is a further investigation into the role of the UL8 subunit. We have examined the effects of UL8 protein on the activities of the UL5/52 proteins in the presence of ICP8. Our results show that UL8 protein is required for optimal DNA helicase, DNA-dependent ATPase, and primase activities in the presence of ICP8. Consequently, we propose that UL8 protein mediates an interaction between ICP8 and the UL5/52 proteins, increasing the utilization of ICP8-covered DNA templates.


EXPERIMENTAL PROCEDURES

Materials

Phosphoenolpyruvate (potassium salt) and NADH were purchased from Sigma. [gamma -32P]ATP (3000 Ci/mmol) and [alpha -32P]dATP (3000 Ci/mmol) were purchased from DuPont NEN and Amersham Corp., respectively. Deoxyribonucleotides and ribonucleotides (ultrapure) with the exception of ATP were from Pharmacia Biotech Inc. ATP (lithium salt), leupeptin, pepstatin, and phenylmethanesulfonyl fluoride were obtained from Boehringer Mannheim.

Proteins

T4 polynucleotide kinase was purchased from New England Biolabs Inc. E. coli SSB was obtained from both Pharmacia Biotech Inc. and U. S. Biochemical Corp. Sequenase Version 2.0 and bovine serum albumin (DNase-free) were purchased from U. S. Biochemical Corp. and Pharmacia Biotech Inc., respectively. Rabbit muscle lactate dehydrogenase and pyruvate kinase, as solutions in 50% glycerol, were obtained from Sigma. Standards for SDS-polyacrylamide gel electrophoresis were obtained from Bio-Rad.

ICP8, UL8 protein, and the UL5/52 core enzyme were purified from total cell extracts of Spodoptera frugiperda Sf21 cells infected with Autographa californica nuclear polyhedrosis virus recombinant for the HSV-1 UL29, UL8, and UL5/UL52 genes, respectively (Dodson et al., 1989; Stow, 1992).

Stocks of recombinant A. californica nuclear polyhedrosis virus were prepared in S. frugiperda Sf9 cells as described (Skaliter and Lehman, 1994). Sf21 cells were propagated and infected as described (Skaliter and Lehman, 1994). 48 h (UL8 protein and UL5/52 proteins) or 60 h (ICP8) post-infection, cells were harvested, washed in phosphate-buffered saline, and frozen at -80 °C. All subsequent manipulations were performed on ice or at 4 °C in buffers containing 0.5 µg/ml leupeptin, 0.7 µg/ml pepstatin, and 0.1 m phenylmethanesulfonyl fluoride. The cells were resuspended in buffer A (10 m Tris-HCl, pH 8.0, 10 m KCl, and 1.5 m MgCl2) and allowed to swell for 20 min. The cells were lysed with 10 strokes of a tight-fitting pestle (A), and NaCl was added to 1.2 . After a 30-min extraction, the debris was pelleted by centrifugation at 35,000 rpm for 60 min in a Beckman type 42.1 rotor. Supernatants were dialyzed twice against 2 liters of buffer B (20 m HEPES/NaOH, pH 7.6, 1 m dithiothreitol, 10% glycerol, and 0.1 m EDTA) containing 0.1  (ICP8), 50 m (UL8 protein), or 60 m (UL5/52 proteins) NaCl to give fraction I.

All chromatography steps were performed using a Pharmacia FPLC system at a flow rate of 0.5 ml/min. ICP8 was purified as described previously (Boehmer and Lehman, 1993a). At each stage during the purification of UL8 protein and the UL5/52 core enzyme, chromatography fractions were assayed by SDS-polyacrylamide gel electrophoresis followed by Coomassie Blue staining and by immunoblotting using rabbit sera raised against UL8 protein and the UL5/52 core enzyme (courtesy of I. R. Lehman, Stanford University). Final purity was assessed by densitometric scanning of Coomassie Blue-stained SDS-polyacrylamide gels.

UL8 protein fraction I was loaded onto a 5-ml Econo-Pac HTP cartridge (Bio-Rad) equilibrated with buffer C (50 m imidazole HCl, pH 7.0, 1 m dithiothreitol, 10% glycerol, and 50 m NaCl). The column was washed; proteins were eluted with a 50-ml linear gradient of ammonium sulfate (0-390 m) in buffer C; and 1-ml fractions were collected. Fractions 7-16, containing the peak of UL8 protein, eluting at ~75 m ammonium sulfate, were pooled and dialyzed against 2 liters of buffer D (20 m Tris-HCl, pH 7.5, 1 m dithiothreitol, 10% glycerol, and 0.1 m EDTA) containing 50 m NaCl to give fraction II. Fraction II was applied to a Mono Q HR 5/5 column (Pharmacia Biotech Inc.) equilibrated with buffer D containing 50 m NaCl. The column was washed, and proteins were eluted with a 10-ml linear gradient of NaCl (0.05-0.5 ) in buffer D. Fractions (0.25 ml) containing near homogeneous (>95% pure) UL8 protein, eluting at ~0.3 NaCl, were divided into aliquots, frozen in liquid nitrogen, and stored at -80 °C. The yield of purified UL8 protein was ~3.5 mg from 2.5 g of cell paste.

UL5/52 proteins fraction I was loaded onto a 5-ml HiTrap heparin column (Pharmacia Biotech Inc.) equilibrated with buffer B containing 60 m NaCl. The column was washed; proteins were eluted with a 50-ml linear gradient of NaCl (60-600 m) in buffer B; and 1-ml fractions were collected. Fractions 13-28, containing the bulk of UL5/52 proteins, were pooled (fraction II) and applied directly to a 5-ml Econo-Pac HTP cartridge equilibrated with buffer E (10 m sodium phosphate, pH 7.0, 1 m dithiothreitol, 10% glycerol, and 0.1  NaCl). The column was washed; proteins were eluted with a 50-ml linear gradient of sodium phosphate (0.01-0.2 ) in buffer E; and 1-ml fractions were collected. The column flow-through fraction and fractions 1-12, containing the majority of UL5/52 proteins, were pooled and dialyzed against 2 liters of buffer D containing 50 m NaCl to give fraction III. Fraction III was applied to a Mono Q HR 5/5 column equilibrated with buffer D containing 50 m NaCl. The column was washed, and proteins were eluted with a 10-ml linear gradient of NaCl (0.05-0.4 ), followed by a 1  NaCl step, both in buffer D. Fractions (0.25 ml) containing near homogeneous (>95% pure) UL5/52 proteins, eluting in the 1  NaCl step, were divided into aliquots, frozen in liquid nitrogen, and stored at -80 °C. The yield of purified UL5/52 proteins was ~4.5 mg from 7.5 g of cell paste.

Protein concentrations were determined by using extinction coefficients of 82,720, 130,390, and 171,380 -1 cm-1 at 280 nm for ICP8, UL8 protein, and UL5/52 proteins, respectively. Fig. 1 shows the purified ICP8, UL5/52 proteins, and UL8 protein used in this study. The lower molecular weight species present in the protein preparations were confirmed as proteolytic degradation products by immunoblot analysis.


Fig. 1. SDS-polyacrylamide gel electrophoresis of the HSV-1 DNA replication proteins used in this study. Proteins were purified as described under ``Experimental Procedures.'' 9.5, 8.4, and 24.5 pmol of ICP8, UL5/52 proteins, and UL8 protein, respectively, were resolved by electrophoresis through a 0.1% SDS, 9% polyacrylamide gel (Sambrook et al., 1989), followed by Coomassie Blue staining. Lanes 1-3, ICP8, UL5/52 proteins, and UL8 protein, respectively. The positions of molecular weight standards are indicated. DF, dye front.
[View Larger Version of this Image (45K GIF file)]

DNA Substrates

phi X174 virion DNA was purchased from U. S. Biochemical Corp. Random hexamer oligodeoxyribonucleotide primers were obtained from Life Technologies, Inc. Oligodeoxyribonucleotides were synthesized on an Applied Biosystems DNA synthesizer and purified by electrophoresis through denaturing polyacrylamide gels (Sambrook et al., 1989). The sequences of the oligodeoxyribonucleotides used in this study are shown in Table I. The 90-mer oligodeoxyribonucleotide was formed by ligating 14-mer (residues 1-14), 8-mer (residues 15-22), and 68-mer (residues 23-90) oligodeoxyribonucleotides using a 65-mer oligodeoxyribonucleotide (complementary to residues 10-74) as a scaffold. The product was purified by electrophoresis through denaturing polyacrylamide gels (Sambrook et al., 1989). The DNA helicase substrate was constructed by annealing 5'-32P-labeled 59-mer oligodeoxyribonucleotide (residues 26-59 are complementary to residues 1-34 of the 90-mer oligodeoxyribonucleotide) to the 90-mer oligodeoxyribonucleotide. This produced a Y-shaped partial DNA duplex molecule that possesses a 25-nucleotide 5'-32P-tail that serves as a loading site for the 5' right-arrow 3' translocation of the UL5/52 DNA helicase.

Table I.

Oligodeoxyribonucleotides used in this study

The 27-mer oligodeoxyribonucleotide was complementary to residues 1-27 of the 90-mer oligodeoxyribonucleotide.
Name Sequence

PB-10 5'-GTACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCCGGTACCGCTTTTGCGGTACCG
59-mer 5'-TGTTGGTTCTCGTATGCTGCCGGTCTGCCGAATTCACACCGCCGGCGCCCACCACCACC
90-mer 5'-GGTGGTGGTGGGCGCCGGCGGTGTGAATTCGGCACTGGCCGTCGTATGCTCTTGGTTGTAGGATCCCAGCACATTGAAGGATGCATGGTG

Enzyme Assays

DNA helicase activity was measured by quantitating the displacement of 5'-32P-labeled 59-mer oligodeoxyribonucleotide using the Y-shaped DNA substrate. Reactions (10 µl) were performed at 37 °C in 20 m HEPES/NaOH, pH 7.5, 1 m dithiothreitol, 10% glycerol, and 4.5 m MgCl2 containing 3 m ATP, 0.1 mg/ml bovine serum albumin, 15 n (molecules) DNA substrate, a 5-10-fold molar excess of unlabeled 27-mer oligodeoxyribonucleotide to prevent reannealing of the unwound DNA strand, and the indicated concentrations of UL5/52 proteins, UL8 protein, ICP8, and E-SSB. In this and subsequent assays, E-SSB was added to achieve the indicated protein/nucleotide ratios assuming a site size of 35 nucleotides/tetramer of protein (Lohman and Ferrari, 1994). The reactions were terminated by the addition of 3 µl of 100 m EDTA, pH 8.0, 10% SDS, 40% glycerol, and 0.5% bromphenol blue. The reaction mixtures were resolved by electrophoresis through nondenaturing polyacrylamide gels, and DNA unwinding was measured as described previously (Boehmer et al., 1993).

The hydrolysis of ATP to ADP and Pi was coupled to the oxidation of NADH to NAD+ and was measured by a decrease in the absorbance at 340 nm as a function of time (Boehmer and Emmerson, 1992). Reactions (75 µl) were performed at 37 °C in 20 m HEPES/NaOH, pH 7.6, 1 m dithiothreitol, 10% glycerol, and 3.5 m MgCl2 containing 1 m ATP, 200 µ NADH, 1.5 m phosphoenolpyruvate, 3 units each of lactate dehydrogenase and pyruvate kinase, 100 n (molecules) oligodeoxyribonucleotide PB-10 as cofactor, 25 n UL5/52 proteins, and the indicated concentrations of UL8 protein, ICP8, and E-SSB. The data were collected with a Perkin-Elmer Lambda 2S spectrophotometer using PECSS software Version 4.2 to calculate rates of ATP hydrolysis.

Primase activity was coupled to the incorporation of [32P]dATP by Sequenase. Reactions (20 µl) were performed at 30 °C in 20 m EPPS/NaOH, pH 8.3, 1 m dithiothreitol, 10% glycerol, and 6.5 m MgCl2 containing 1 m each ATP, CTP, GTP, and UTP, 40 µ each dCTP, dGTP, and dTTP, 20 µ [32P]dATP (~3500 µCi/µmol), 0.1 mg/ml bovine serum albumin, 1 unit of Sequenase, 1.43 n (molecules) phi X174 virion DNA as template, and the indicated concentrations of UL5/52 proteins, UL8 protein, ICP8, and E-SSB. After 60 min, the reaction mixtures were spotted onto individual discs of DE81 paper (Whatman), followed by three 10-min washes in 0.5  sodium phosphate, pH 7.0, and one wash in 95% ethanol. The DE81 paper discs were dried, and their radioactivity was determined by scintillation counting.


RESULTS

Effects of ICP8, E-SSB, and UL8 Protein on the DNA Helicase Activity of the UL5/52 Proteins

Fig. 2 shows the ability of the UL5/52 proteins to utilize the Y-shaped partial DNA duplex molecule as a substrate for helicase action. High concentrations of UL5/52 proteins (>250 n) were required to unwind >50% of the DNA substrate. In contrast to the DNA primase activity (Crute and Lehman, 1991), the DNA helicase activity of the UL5/52 proteins was observed to be most active at pH 7.0-7.5, with virtually undetectable levels of activity at pH 8.0-8.6 (data not shown).


Fig. 2. DNA unwinding of the Y-shaped partial DNA duplex molecule by the UL5/52 proteins. Reactions were performed as described under ``Experimental Procedures'' for 60 min with the indicated concentrations of UL5/52 proteins. A, autoradiogram of the reaction products. Lane 1, no protein; lanes 2-7, 12.5, 25, 50, 100, 250, and 500 n UL5/52 proteins, respectively; lane 8, heat-denatured DNA substrate. B, quantitation of the data shown in A.
[View Larger Version of this Image (32K GIF file)]

Fig. 3 shows the effect of ICP8 on the helicase activity of the UL5/52 proteins. The data indicate that concentrations of ICP8 in excess of those of the UL5/52 proteins (>150 n) could stimulate the helicase activity of the UL5/52 proteins up to 3-fold (Fig. 3A). There was no significant DNA unwinding activity in the presence of ICP8 alone. Fig. 3B shows the stimulatory effect of ICP8 on the kinetics of DNA unwinding by the UL5/52 proteins.


Fig. 3. Effect of ICP8 on the helicase activity of the UL5/52 proteins. Reactions were performed as described under ``Experimental Procedures.'' A, 60-min reactions containing 150 n UL5/52 proteins and ICP8 as indicated. Column 1, no protein; column 2, UL5/52 proteins; column 3, UL5/52 proteins and 100 n ICP8; column 4, UL5/52 proteins and 150 n ICP8; column 5, UL5/52 proteins and 300 n ICP8; column 6, UL5/52 proteins and 450 n ICP8; columns 7 and 8, 300 and 450 n ICP8 alone, respectively. B, time course of DNA unwinding in reactions containing 125 n UL5/52 proteins in the absence (open circle ) or presence (bullet ) of 300 n ICP8.
[View Larger Version of this Image (19K GIF file)]

Fig. 4 shows the effect of UL8 protein on the helicase activity of the UL5/52 proteins in the absence or presence of equimolar (300 n) or excess (450 n) ICP8. Where indicated, UL8 protein was present at a 3-fold molar excess over the UL5/52 proteins. This ratio had previously been employed by Tenney et al. (1994) to examine the effect of UL8 protein on the primase activity of the UL5/52 proteins. The addition of this level of UL8 protein had no significant effect on the helicase activity of the UL5/52 proteins (Fig. 4). Further titration of UL8 protein showed no effect on DNA unwinding even when present at a 6-fold molar excess over UL5/52 proteins (data not shown).


Fig. 4. Effect of UL8 protein on the DNA helicase activity of the UL5/52 proteins in the absence or presence of ICP8. Reactions were performed as described under ``Experimental Procedures'' for 60 min with 300 n UL5/52 proteins, 900 n UL8 protein, and ICP8 as indicated. Column 1, no protein; column 2, UL5/52 proteins; column 3, UL5/52 proteins and UL8 protein; column 4, UL5/52 proteins and 300 n ICP8; column 5, UL5/52 proteins, UL8 protein, and 300 n ICP8; column 6, UL5/52 proteins and 450 n ICP8; column 7, UL5/52 proteins, UL8 protein, and 450 n ICP8.
[View Larger Version of this Image (26K GIF file)]

The addition of UL8 protein to reactions containing UL5/52 proteins and ICP8 markedly increased the level of stimulation of helicase activity observed with ICP8 alone (Fig. 4). While ICP8 concentrations of 300 and 450 n increased DNA unwinding 1.6- and 3.6-fold, respectively, the presence of UL8 protein boosted this stimulation to 3.1- and 8.6-fold, respectively. Increasing the ratio of UL8 protein to UL5/52 proteins did not significantly modulate the stimulatory effect observed in the presence of ICP8 (data not shown). Fig. 5 shows the synergistic effect of ICP8 and UL8 protein on the kinetics of DNA unwinding by the UL5/52 proteins.


Fig. 5. Effect of UL8 protein on the kinetics of DNA unwinding by the UL5/52 proteins in the absence or presence of ICP8. Reactions containing the indicated concentrations of UL5/52 proteins, UL8 protein, and ICP8 were performed as described under ``Experimental Procedures.'' At the times indicated, aliquots were removed to measure helicase activity. open circle , 300 n UL5/52 proteins; square , 300 n UL5/52 proteins and 900 n UL8 protein; bullet , 300 n UL5/52 proteins and 300 n ICP8; triangle , 300 n UL5/52 proteins, 900 n UL8 protein, and 300 n ICP8.
[View Larger Version of this Image (17K GIF file)]

Fig. 6 shows that heterologous E. coli SSB could not substitute for ICP8 in this synergistic response. The addition of UL8 protein to reactions containing 300 n ICP8 stimulated DNA unwinding by the UL5/52 proteins from 2.3- to 5.6-fold. In contrast, equimolar concentrations of E-SSB led to inhibition of DNA unwinding by the UL5/52 proteins, both in the absence and presence of UL8 protein. The additive effect of ICP8 and UL8 protein on the helicase activity of the UL5/52 proteins was also observed using a DNA substrate in which a 3'-tailed oligodeoxyribonucleotide was annealed to single-strand M13 DNA (data not shown). The results show representative data that were reproducibly observed in three independent experiments.


Fig. 6. E. coli SSB cannot substitute for ICP8 in the UL8 protein-dependent stimulation of the helicase activity of the UL5/52 proteins. Reactions were performed as described under ``Experimental Procedures'' for 60 min with 250 n UL5/52 proteins, 750 n UL8 protein, and 300 n ICP8 or E. coli SSB as indicated. Column 1, no protein; column 2, UL5/52 proteins; column 3, UL5/52 proteins and UL8 protein; column 4, UL5/52 proteins and ICP8; column 5, UL5/52 proteins and E-SSB; column 6, UL5/52 proteins, UL8 protein, and ICP8; column 7, UL5/52 proteins, UL8 protein, and E-SSB.
[View Larger Version of this Image (24K GIF file)]

Effects of ICP8, E-SSB, and UL8 Protein on the DNA-dependent ATPase Activity of the UL5/52 Proteins

The dependence of helicase action on ATP hydrolysis led us to examine the effects of ICP8, E-SSB, and UL8 protein on the DNA-dependent ATPase activity of the UL5/52 proteins. Under the conditions used in this study, DNA-dependent ATP hydrolysis by the UL5/52 proteins proceeded with linear kinetics (Fig. 7). When included, UL8 protein was present at a 3-fold molar excess over the UL5/52 proteins.


Fig. 7. DNA-dependent ATPase activity of the UL5/52 proteins. This representative time course shows the linear kinetics of ATP hydrolysis by the UL5/52 proteins. The reaction was performed as described under ``Experimental Procedures.'' The arrow indicates the time of addition of the UL5/52 proteins. Abscissa, time (seconds); ordinate, absorbance at 340 nm.
[View Larger Version of this Image (13K GIF file)]

Fig. 8 shows the effects of ICP8, E-SSB, and UL8 protein on the rate of ATP hydrolysis by the UL5/52 proteins. There was no significant effect on the rate of ATP hydrolysis in the presence of UL8 protein. In contrast, ICP8 or E-SSB caused significant inhibition, depending on the protein/nucleotide ratio. An ICP8/nucleotide ratio of 1:7.5, which is in excess of the concentration required to coat the DNA template, reduced the rate of ATP hydrolysis to 36%. At an ICP8/nucleotide ratio of 1:15, the rate of ATP hydrolysis was reduced to 75%. Similarly, a reduction in the rate of ATP hydrolysis was observed at E-SSB concentrations that were in excess or sufficient to coat the DNA template. Thus, E-SSB/nucleotide ratios of 1:17.5 and 1:35 reduced the rate of ATP hydrolysis to 26 and 41%, respectively. The addition of UL8 protein to reactions containing ICP8 resulted in partial or complete restoration of the rate of ATP hydrolysis, depending on the concentration of ICP8. The addition of UL8 protein at an ICP8/nucleotide ratio of 1:7.5 increased the rate of ATP hydrolysis to 51%. Complete (95%) restoration of the rate of ATP hydrolysis was observed in the presence of UL8 protein at an ICP8/nucleotide ratio of 1:15. In contrast, the addition of UL8 protein to reactions containing E-SSB did not increase the rate of ATP hydrolysis. The ability of UL8 protein to increase the rate of ATP hydrolysis in reactions inhibited by the addition of ICP8, but not in those with E-SSB, was also observed at lower protein/nucleotide ratios (data not shown). These effects were observed in several independent experiments.


Fig. 8. Effects of ICP8, E-SSB, and UL8 protein on the DNA-dependent ATPase activity of the UL5/52 proteins. Reactions were performed as described under ``Experimental Procedures.'' Where indicated, UL8 protein was present at 75 n. Numbers in parentheses (see below) represent ICP8/nucleotide and E-SSB/nucleotide ratios. ICP8/nucleotide ratios of 1:7.5 and 1:15 correspond to 800 and 400 n ICP8, respectively. E-SSB/nucleotide ratios of 1:17.5 and 1:35 correspond to 342.9 and 171.4 n E-SSB, respectively. Column 1, UL5/52 proteins; column 2, UL5/52 proteins and UL8 protein; column 3, UL5/52 proteins and ICP8 (1:7.5); column 4, UL5/52 proteins and E-SSB (1:17.5); column 5, UL5/52 proteins, UL8 protein, and ICP8 (1:7.5); column 6, UL5/52 proteins, UL8 protein, and E-SSB (1:17.5); column 7, UL5/52 proteins and ICP8 (1:15); column 8, UL5/52 proteins and E-SSB (1:35); column 9, UL5/52 proteins, UL8 protein, and ICP8 (1:15); column 10, UL5/52 proteins, UL8 protein, and E-SSB (1:35).
[View Larger Version of this Image (49K GIF file)]

Effects of ICP8, E-SSB, and UL8 Protein on the Primase Activity of the UL5/52 Proteins

In this study, the primase activity of the UL5/52 proteins was measured using a coupled assay in which RNA primers were extended by Sequenase DNA polymerase using single-strand phi X174 DNA as template. To determine the effects of ICP8, E-SSB, and UL8 protein on primase activity, it was imperative to exclude any secondary effects of these proteins on Sequenase activity. Table II shows that UL8 protein had no significant effect on the DNA polymerase activity of Sequenase using single-strand phi X174 DNA primed with random hexamer oligodeoxyribonucleotides. In contrast, the addition of ICP8 or E-SSB reduced DNA synthesis to 53 and 75% of the normal level, respectively. Similar results were obtained when using singly primed M13 DNA as template instead of random-primed phi X174 DNA (data not shown). The concentrations of ICP8 and E-SSB used were in excess of those required to coat the DNA template, representing protein/nucleotide ratios of 1:15 and 1:17.5, respectively, and were the highest concentrations used in the primase assays. The magnitudes of the effects of ICP8 and E-SSB on Sequenase activity cannot account for their strong inhibition of UL5/52 primase-dependent DNA synthesis (see Figs. 9 and 10). Consequently, it is reasonable to assume that the observed effects of ICP8, E-SSB, and UL8 protein are due to modulation of primase activity and not of Sequenase activity.

Table II.

Effects of ICP8, E-SSB, and UL8 protein on DNA synthesis by Sequenase

Reactions were performed as described for the primase assay under ``Experimental Procedures,'' except that nucleoside triphosphates were omitted, the MgCl2 concentration was 2.5 m, and the template was pre-primed with 0.036 A260 units/assay of random hexamer oligodeoxyribonucleotides. ICP8 and E-SSB were present at protein/nucleotide ratios of 1:15 (513 n) and 1:17.5 (440 n), respectively. UL8 protein was present at 75 n. The results reflect the average of two separate experiments.
Addition dNMP incorporated Activitya

pmol %
None 166.9  ± 2.7 100
ICP8 88.0  ± 0.1 53
E-SSB 124.6  ± 0.1 75
UL8 protein 179.0  ± 1.7 107

a  Normalized with respect to the reaction with Sequenase only.


Fig. 9. Effects of ICP8, E-SSB, and UL8 protein on the primase activity of the UL5/52 proteins. Reactions were performed as described under ``Experimental Procedures'' with 25 n UL5/52 proteins, 75 n UL8 protein, and ICP8 or E-SSB as indicated. Numbers in parentheses (see below) represent ICP8/nucleotide and E-SSB/nucleotide ratios. ICP8/nucleotide ratios of 1:15, 1:30, and 1:60 correspond to 513, 257, and 128 n ICP8, respectively. E-SSB/nucleotide ratios of 1:17.5, 1:35, and 1:70 correspond to 440, 220, and 110 n E-SSB, respectively. Column 1, UL5/52 proteins; column 2, UL5/52 proteins and UL8 protein; column 3, UL5/52 proteins and ICP8 (1:15); column 4, UL5/52 proteins and E-SSB (1:17.5); column 5, UL5/52 proteins, UL8 protein, and ICP8 (1:15); column 6, UL5/52 proteins, UL8 protein, and E-SSB (1:17.5); column 7, UL5/52 proteins and ICP8 (1:30); column 8, UL5/52 proteins and E-SSB (1:35); column 9, UL5/52 proteins, UL8 protein, and ICP8 (1:30); column 10, UL5/52 proteins, UL8 protein, and E-SSB (1:35); column 11, UL5/52 proteins and ICP8 (1:60); column 12, UL5/52 proteins and E-SSB (1:70); column 13, UL5/52 proteins, UL8 protein, and ICP8 (1:60); column 14, UL5/52 proteins, UL8 protein, and E-SSB (1:70). The results reflect the average of two separate experiments.
[View Larger Version of this Image (35K GIF file)]


Fig. 10. Partial UL8 protein-dependent restoration of UL5/52 primase activity in the presence of ICP8. Reactions were performed as described under ``Experimental Procedures.'' Where indicated, ICP8 was present at a protein/nucleotide ratio of 1:15, corresponding to 513 n ICP8. At each concentration of UL5/52 proteins, UL8 protein was present at a 3-fold molar excess. open circle , UL5/52 proteins; square , UL5/52 proteins and UL8 protein; bullet , UL5/52 proteins and ICP8; triangle , UL5/52 proteins, UL8 protein, and ICP8. The results reflect the average of two separate experiments.
[View Larger Version of this Image (20K GIF file)]

Figs. 9 and 10 show the effects of ICP8 and E-SSB on the primase activity of the UL5/52 proteins in the absence and presence of UL8 protein. Where indicated, UL8 protein was present at a 3-fold molar excess over the UL5/52 proteins. Consistent with the observations of Tenney et al. (1994), a 3-fold molar excess of UL8 protein could stimulate the primase activity of the core enzyme up to 3-fold (see Fig. 10).

Fig. 9 shows that while UL8 protein alone could stimulate primase activity by a factor of 1.3, ICP8 or E-SSB caused significant inhibition, depending on the protein/nucleotide ratio. An ICP8/nucleotide ratio of 1:15, which is sufficient to coat the DNA template, resulted in almost complete inhibition, with 7% residual activity. In contrast, ICP8/nucleotide ratios of 1:30 and 1:60 resulted in much lower levels of inhibition, with 56 and 78% residual activity, respectively. Virtually complete inhibition of primase activity was observed at E-SSB concentrations that were in excess or sufficient to coat the DNA template. Thus, E-SSB/nucleotide ratios of 1:17.5 and 1:35 resulted in 4 and 7% residual activity, respectively. The inhibitory effect of E-SSB was less severe at a ratio of 1:70, with 27% residual activity. The addition of UL8 protein to reactions containing ICP8 resulted in a partial or complete reversal of the inhibition, depending on the concentration of ICP8. At ICP8/nucleotide ratios of 1:15 and 1:30, primase activity was increased to 24 and 74%, respectively. The addition of UL8 protein to reactions containing an ICP8/nucleotide ratio of 1:60 led to complete (98.5%) restoration of primase activity. In contrast, the addition of UL8 protein to reactions containing E-SSB did not restore primase activity.

The stimulatory effect of UL8 protein on the UL5/52 primase and the partial UL8 protein-dependent rescue from inhibition by ICP8, present at a protein/nucleotide ratio of 1:15, were observed at all concentrations of UL5/52 proteins examined (Fig. 10). Titration of the molar ratio of UL8 protein to UL5/52 proteins from 0.5 to 15:1 did not enhance the rescue from inhibition by ICP8 (data not shown).


DISCUSSION

We have examined the effect of UL8 protein on the utilization of SSB-covered DNA templates by the UL5/52 DNA helicase-primase core enzyme. In the absence of HSV-1 SSB, ICP8, or E-SSB, UL8 protein had no significant effects on the DNA helicase or DNA-dependent ATPase activities of the UL5/52 proteins. These observations are consistent with data from other laboratories (Calder and Stow, 1990; Dodson and Lehman, 1991). In addition, as previously reported by Tenney et al. (1994), UL8 protein could stimulate the primase activity of the UL5/52 proteins ~3-fold.

In the absence of UL8 protein, ICP8 stimulated the DNA helicase activity of the UL5/52 proteins ~3-fold. This observation is not surprising since SSBs frequently stimulate DNA unwinding (Kornberg and Baker, 1992; Lohman and Bjornson, 1996). The stimulatory effect of ICP8 was specific since heterologous E-SSB could not substitute for ICP8, suggesting that ICP8 is not merely stabilizing unwound regions of DNA. Consequently, the ability of ICP8 to stimulate the DNA helicase activity of the UL5/52 proteins is indicative of a specific physical interaction between these proteins. Consistent with our finding, Crute and Lehman (1991) had previously reported the specific requirement for ICP8 in the unwinding of nicked plasmids by the HSV-1 DNA helicase-primase holoenzyme.

The primase and DNA-dependent ATPase activities of the UL5/52 core enzyme were strongly inhibited by ICP8 or E-SSB in a manner that varied with the SSB/nucleotide ratio. This observation may be rationalized by assuming that SSBs prevent access of the UL5/52 proteins to the DNA template.

The addition of UL8 protein to reactions containing ICP8 and the UL5/52 core enzyme led to further stimulation of DNA unwinding and to reversal of inhibition of the primase and DNA-dependent ATPase activities. These effects were specific for ICP8-covered DNA templates since UL8 protein failed to stimulate reactions containing E-SSB.

The DNA helicase-primase holoenzyme purified from HSV-1-infected cells consists of a 1:1:1 complex of the UL5, UL8, and UL52 subunits (Crute and Lehman, 1991). However, it is unclear what the relative ratios of these proteins are in vivo. The only data regarding this issue are that the UL8 transcript (Baradaran et al., 1994) and protein (Olivo et al., 1989), like those for the UL5 and UL52 genes, are of relatively low abundance. In our experiments, UL8 protein was added to the core enzyme to reconstitute the heterotrimeric holoenzyme. Tenney et al. (1994) reported that optimal in vitro reconstitution of the holoenzyme was achieved at a molar ratio of UL8 protein to UL5/52 proteins of 3:1. Accordingly, in our experiments, UL8 protein was present at a 3-fold molar excess over the UL5/52 proteins. In vivo, we envisage that the UL5/8/52 heterotrimer interaction with ICP8-covered DNA templates would not require an excess of UL8 protein.

We propose that UL8 protein functions in a manner analogous to the bacteriophage T4 gene 59 protein and the E. coli DnaC protein. The T4 gene 59 protein has been reported to interact with T4 SSB (gene 32 protein)-coated single-strand DNA, and the DNA helicase component (gene 41 protein) of the T4 DNA helicase-primase (gene 41/61 proteins) (Barry and Alberts, 1994a, 1994b; Morrical et al., 1994; Yonesaki, 1994). Consequently, its proposed role is to facilitate loading of the T4 DNA helicase-primase onto DNA templates coated with gene 32 protein to initiate lagging-strand DNA synthesis. The situation during E. coli replication is more complex (reviewed by Kornberg and Baker (1992)). In this system, the DnaC protein loads the DnaB helicase, and subsequently the DnaG primase, onto E-SSB-coated DNA templates, either in reactions that require DnaA protein and a DnaA protein recognition site or in combination with the primosome proteins PriA, PriB, and PriC and a primosome assembly site.

Based on the ability of UL8 protein to mediate a functional interaction between ICP8 and the UL5/52 core enzyme, we hypothesize that there may be a direct interaction between these proteins. In the physiological state, during DNA replication, this interaction would optimize the utilization of ICP8-covered DNA templates. Our assumption of the existence of protein-protein interactions between the subunits of the HSV-1 DNA helicase-primase and ICP8 is supported by the finding that anti-ICP8 rabbit serum can immunoprecipitate a protein complex that contains the HSV-1 DNA helicase-primase holoenzyme, the heterodimeric DNA polymerase, and ICP8 (Skaliter and Lehman, 1994).


FOOTNOTES

*   This work was supported in part by Grant AI 38335 from the National Institutes of Health, a grant from the Ruth Estrin Goldberg Memorial for Cancer Research, and Grant 13-96 from the Foundation of the University of Medicine and Dentistry of New Jersey (to P. E. B.) and by Grant 5036 from the Association pour la Recherche sur le Cancer (to G. V.). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
   To whom correspondence should be addressed. Tel.: 201-982-5215; Fax: 201-982-3644; E-mail: boehmepe{at}njmsa.umdnj.edu.
1   The abbreviations used are: HSV-1, herpes simplex virus type-1; SSB, single-strand DNA-binding protein; E-SSB, E. coli SSB; EPPS, N-2-hydroxyethylpiperazine-N'-3-propanesulfonic acid.

Acknowledgment

We are grateful to M.-J. Pillaire for the construction of the Y-shaped DNA helicase substrate.


REFERENCES

  1. Baradaran, K., Dabrowski, C. E., Schaffer, P. A. (1994) J. Virol. 68, 4251-4261 [Abstract/Free Full Text]
  2. Barry, J., Alberts, B. (1994a) J. Biol. Chem. 269, 33049-33062 [Abstract/Free Full Text]
  3. Barry, J., Alberts, B. (1994b) J. Biol. Chem. 269, 33063-33068 [Abstract/Free Full Text]
  4. Boehmer, P. E., Emmerson, P. T. (1992) J. Biol. Chem. 267, 4981-4987 [Abstract/Free Full Text]
  5. Boehmer, P. E., Lehman, I. R. (1993a) Proc. Natl. Acad. Sci. U. S. A. 90, 8444-8448 [Abstract/Free Full Text]
  6. Boehmer, P. E., Lehman, I. R. (1993b) J. Virol. 67, 711-715 [Abstract/Free Full Text]
  7. Boehmer, P. E., Dodson, M. S., Lehman, I. R. (1993) J. Biol. Chem. 268, 1220-1225 [Abstract/Free Full Text]
  8. Boehmer, P. E., Craigie, M. C., Stow, N. D., Lehman, I. R. (1994) J. Biol. Chem. 269, 29329-29334 [Abstract/Free Full Text]
  9. Calder, J. M., Stow, N. D. (1990) Nucleic Acids Res. 18, 3573-3578 [Abstract/Free Full Text]
  10. Challberg, M. D. (1991) Semin. Virol. 2, 247-256
  11. Chiou, H. C., Weller, S. K., Coen, D. M. (1985) Virology 145, 213-226 [CrossRef][Medline] [Order article via Infotrieve]
  12. Crute, J. J., Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488 [Abstract/Free Full Text]
  13. Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189 [Abstract/Free Full Text]
  14. Dodson, M. S., Lehman, I. R. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 1105-1109 [Abstract/Free Full Text]
  15. Dodson, M. S., Crute, J. J., Bruckner, R. C., Lehman, I. R. (1989) J. Biol. Chem. 264, 20835-20838 [Abstract/Free Full Text]
  16. Gupte, S. S., Olson, J. W., Ruyechan, W. T. (1991) J. Biol. Chem. 266, 11413-11416 [Abstract/Free Full Text]
  17. Hernandez, T. R., Lehman, I. R. (1990) J. Biol. Chem. 265, 11227-11232 [Abstract/Free Full Text]
  18. Kornberg, A., Baker, T. (1992) DNA Replication , W. H. Freeman & Co., New York
  19. Lee, C. K., Knipe, D. M. (1985) J. Virol. 54, 731-738 [Abstract/Free Full Text]
  20. Liptak, L. M., Uprichard, S. L., Knipe, D. M. (1996) J. Virol. 70, 1759-1767 [Abstract]
  21. Lohman, T. M., Ferrari, M. E. (1994) Annu. Rev. Biochem. 63, 527-570 [Medline] [Order article via Infotrieve]
  22. Lohman, T. M., Bjornson, K. P. (1996) Annu. Rev. Biochem. 65, 169-214 [CrossRef][Medline] [Order article via Infotrieve]
  23. Lukonis, C. J., Weller, S. K. (1996) J. Virol. 70, 1751-1758 [Abstract]
  24. Makhov, A. M., Boehmer, P. E., Lehman, I. R., Griffith, J. D. (1996) J. Mol. Biol. 258, 789-799 [CrossRef][Medline] [Order article via Infotrieve]
  25. Morrical, S. W., Hempstead, K., Morrical, M. D. (1994) J. Biol. Chem. 269, 33069-33081 [Abstract/Free Full Text]
  26. O'Donnell, M. E., Elias, P., Funnell, B. E., Lehman, I. R. (1987) J. Biol. Chem. 262, 4260-4266 [Abstract/Free Full Text]
  27. Olivo, P. D., Nelson, N. J., Challberg, M. D. (1989) J. Virol. 63, 196-204 [Abstract/Free Full Text]
  28. Parry, M. E., Stow, N. D., Marsden, H. S. (1993) J. Gen. Virol. 74, 607-612 [Abstract/Free Full Text]
  29. Ruyechan, R. T. (1983) J. Virol. 46, 661-666 [Abstract/Free Full Text]
  30. Sambrook, J., Fritsch, E. F., Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  31. Sherman, G., Gottlieb, J., Challberg, M. D. (1992) J. Virol. 66, 4884-4892 [Abstract/Free Full Text]
  32. Skaliter, R., Lehman, I. R. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 10665-10669 [Abstract/Free Full Text]
  33. Stow, N. D. (1992) J. Gen. Virol. 73, 313-321 [Abstract/Free Full Text]
  34. Tenney, D. J., Hurlburt, W. W., Micheletti, P. A., Bifano, M., Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035 [Abstract/Free Full Text]
  35. Tenney, D. J., Sheaffer, A. K., Hurlburt, W. W., Bifano, M., Hamatake, R. K. (1995) J. Biol. Chem. 270, 9129-9136 [Abstract/Free Full Text]
  36. Thomas, M. S., Gao, M., Knipe, D. M., Powell, K. L. (1992) J. Virol. 66, 1152-1161 [Abstract/Free Full Text]
  37. Vaughan, P. J., Purifoy, D. J. M., Powell, K. L. (1985) J. Virol. 53, 501-508 [Abstract/Free Full Text]
  38. Wu, C. A., Nelson, N. J., McGeoch, D. J., Challberg, M. D. (1988) J. Virol. 62, 435-443 [Abstract/Free Full Text]
  39. Yonesaki, T. (1994) J. Biol. Chem. 269, 1284-1289 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. A. Cavanaugh and R. D. Kuchta
Initiation of New DNA Strands by the Herpes Simplex Virus-1 Primase-Helicase Complex and Either Herpes DNA Polymerase or Human DNA Polymerase {alpha}
J. Biol. Chem., January 16, 2009; 284(3): 1523 - 1532.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Chen, C. M. Livingston, S. D. Carrington-Lawrence, P. Bai, and S. K. Weller
A Mutation in the Human Herpes Simplex Virus Type 1 UL52 Zinc Finger Motif Results in Defective Primase Activity but Can Recruit Viral Polymerase and Support Viral Replication Efficiently
J. Virol., August 15, 2007; 81(16): 8742 - 8751.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Slanina, S. Weger, N. D. Stow, A. Kuhrs, and R. Heilbronn
Role of the Herpes Simplex Virus Helicase-Primase Complex during Adeno-Associated Virus DNA Replication.
J. Virol., June 1, 2006; 80(11): 5241 - 5250.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Chen, S. D. Carrington-Lawrence, P. Bai, and S. K. Weller
Mutations in the Putative Zinc-Binding Motif of UL52 Demonstrate a Complex Interdependence between the UL5 and UL52 Subunits of the Human Herpes Simplex Virus Type 1 Helicase/Primase Complex
J. Virol., July 15, 2005; 79(14): 9088 - 9096.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. V. Nimonkar and P. E. Boehmer
Role of Protein-Protein Interactions during Herpes Simplex Virus Type 1 Recombination-dependent Replication
J. Biol. Chem., May 21, 2004; 279(21): 21957 - 21965.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Korhonen, M. Gaspari, and M. Falkenberg
TWINKLE Has 5' -> 3' DNA Helicase Activity and Is Specifically Stimulated by Mitochondrial Single-stranded DNA-binding Protein
J. Biol. Chem., December 5, 2003; 278(49): 48627 - 48632.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
R. Heilbronn, M. Engstler, S. Weger, A. Krahn, C. Schetter, and M. Boshart
ssDNA-dependent colocalization of adeno-associated virus Rep and herpes simplex virus ICP8 in nuclear replication domains
Nucleic Acids Res., November 1, 2003; 31(21): 6206 - 6213.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. V. Nimonkar and P. E. Boehmer
Reconstitution of recombination-dependent DNA synthesis in herpes simplex virus 1
PNAS, September 2, 2003; 100(18): 10201 - 10206.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. D. Carrington-Lawrence and S. K. Weller
Recruitment of Polymerase to Herpes Simplex Virus Type 1 Replication Foci in Cells Expressing Mutant Primase (UL52) Proteins
J. Virol., April 1, 2003; 77(7): 4237 - 4247.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Gascon, J. L. Carrascosa, L. Villar, J. M. Lazaro, and M. Salas
Importance of the N-terminal Region of the Phage GA-1 Single-stranded DNA-binding Protein for Its Self-interaction Ability and Functionality
J. Biol. Chem., June 14, 2002; 277(25): 22534 - 22540.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. V. Nimonkar and P. E. Boehmer
In Vitro Strand Exchange Promoted by the Herpes Simplex Virus Type-1 Single Strand DNA-binding Protein (ICP8) and DNA Helicase-Primase
J. Biol. Chem., April 19, 2002; 277(17): 15182 - 15189.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Mapelli, M. Mühleisen, G. Persico, H. van der Zandt, and P. A. Tucker
The 60-Residue C-Terminal Region of the Single-Stranded DNA Binding Protein of Herpes Simplex Virus Type 1 Is Required for Cooperative DNA Binding
J. Virol., October 1, 2000; 74(19): 8812 - 8822.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Falkenberg, I. R. Lehman, and P. Elias
Leading and lagging strand DNA synthesis in vitro by a reconstituted herpes simplex virus type 1 replisome
PNAS, April 11, 2000; 97(8): 3896 - 3900.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-S. Gourves, N. T. Le Gac, G. Villani, P. E. Boehmer, and N. P. Johnson
Equilibrium Binding of Single-stranded DNA with Herpes Simplex Virus Type I-coded Single-stranded DNA-binding Protein, ICP8
J. Biol. Chem., April 6, 2000; 275(15): 10864 - 10869.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. R. Lehman and P. E. Boehmer
Replication of Herpes Simplex Virus DNA
J. Biol. Chem., October 1, 1999; 274(40): 28059 - 28062.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Biswas and S. K. Weller
A Mutation in the C-terminal Putative Zn2+ Finger Motif of UL52 Severely Affects the Biochemical Activities of the HSV-1 Helicase-Primase Subcomplex
J. Biol. Chem., March 19, 1999; 274(12): 8068 - 8076.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. Evans, G. Rosenblatt, D. Leisy, and G. Rohrmann
Characterization of the interaction between the baculovirus ssDNA- binding protein (LEF-3) and putative helicase (P143)
J. Gen. Virol., February 1, 1999; 80(2): 493 - 500.
[Abstract]


Home page
J. Biol. Chem.Home page
N. T. Le Gac, G. Villani, and P. E. Boehmer
Herpes Simplex Virus Type-1 Single-strand DNA-binding Protein (ICP8) Enhances the Ability of the Viral DNA Helicase-primase to Unwind Cisplatin-modified DNA
J. Biol. Chem., May 29, 1998; 273(22): 13801 - 13807.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Barrera, D. Bloom, and M. Challberg
An Intertypic Herpes Simplex Virus Helicase-Primase Complex Associated with a Defect in Neurovirulence Has Reduced Primase Activity
J. Virol., February 1, 1998; 72(2): 1203 - 1209.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. E. Boehmer
The Herpes Simplex Virus Type-1 Single-strand DNA-binding Protein, ICP8, Increases the Processivity of the UL9 Protein DNA Helicase
J. Biol. Chem., January 30, 1998; 273(5): 2676 - 2683.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. C. Dudas and W. T. Ruyechan
Identification of a Region of the Herpes Simplex Virus Single-Stranded DNA-Binding Protein Involved in Cooperative Binding
J. Virol., January 1, 1998; 72(1): 257 - 265.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J Schmitt and G. Keil
Characterization of the bovine herpesvirus 1 UL8 gene and gene products
J. Gen. Virol., January 1, 1998; 79(1): 133 - 141.
[Abstract]


Home page
J. Biol. Chem.Home page
M. Falkenberg, D. A. Bushnell, P. Elias, and I. R. Lehman
The UL8 Subunit of the Heterotrimeric Herpes Simplex Virus Type 1 Helicase-Primase Is Required for the Unwinding of Single Strand DNA-binding Protein (ICP8)-coated DNA Substrates
J. Biol. Chem., September 5, 1997; 272(36): 22766 - 22770.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Biswas and S. K. Weller
The UL5 and UL52 Subunits of the Herpes Simplex Virus Type 1 Helicase-Primase Subcomplex Exhibit a Complex Interdependence for DNA Binding
J. Biol. Chem., May 11, 2001; 276(20): 17610 - 17619.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gac, N. T. L.
Right arrow Articles by Boehmer, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gac, N. T. L.
Right arrow Articles by Boehmer, P. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement